ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
2,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
3,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
4,1,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
4,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
5,1,Cardiac failure,Heart failures NEC,Heart failures,Card,Y
5,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
5,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
6,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
8,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
8,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
8,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
9,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
10,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
12,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
13,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
13,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
14,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
15,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
15,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
15,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
15,4,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
16,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
16,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
16,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
16,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
17,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
18,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
18,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
18,3,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
19,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
19,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
19,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
20,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
21,1,Optic neuropathy,Visual pathway disorders,Vision disorders,Eye,N
22,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
23,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
23,2,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
24,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
25,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
25,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
26,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
26,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
26,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
26,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
26,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
27,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
28,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
28,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
28,3,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
28,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
28,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
29,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
30,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
30,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
31,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
31,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
31,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
32,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
32,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
32,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
33,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
34,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
35,1,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
35,2,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
36,1,Deafness,Hearing losses,Hearing disorders,Ear,N
37,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
38,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
38,2,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
38,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
39,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
40,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
40,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
40,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
40,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
40,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
41,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
41,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
41,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
41,4,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
41,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
42,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
43,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
43,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
43,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
43,4,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
44,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
44,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
45,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
45,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
45,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
46,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
47,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
47,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
47,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
48,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
48,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
49,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
50,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
50,2,Bradyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
50,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
51,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
51,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
51,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
51,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
52,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
52,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
53,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
54,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
54,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
55,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
55,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
56,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
57,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
58,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
59,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
60,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
61,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
61,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
61,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
62,1,Alcohol intolerance,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
62,2,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
62,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
63,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
64,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
65,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,Y
65,2,Vaginal infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
66,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Headache,Headaches NEC,Headaches,Nerv,N
68,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
69,1,Application site reaction,Application site reactions,Administration site reactions,Genrl,N
69,2,Headache,Headaches NEC,Headaches,Nerv,N
70,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
70,2,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
70,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
70,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
71,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
72,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
72,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
72,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
72,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
73,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
73,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
74,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
74,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
74,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
75,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
76,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
76,2,Headache,Headaches NEC,Headaches,Nerv,N
76,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
77,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
78,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,1,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
80,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
80,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
80,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
81,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
81,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
81,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
81,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
82,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
83,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
83,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
83,3,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
84,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
84,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
85,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
86,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
87,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
88,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
89,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
90,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
90,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
90,3,Headache,Headaches NEC,Headaches,Nerv,N
90,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
90,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
90,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
91,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
92,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
93,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
93,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
94,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
95,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
96,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
96,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
96,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
97,1,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
98,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
99,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
99,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
99,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
99,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
100,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
100,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
101,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
102,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
103,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
104,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
104,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
105,1,Atrioventricular block complete,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
106,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
107,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
108,1,Burning sensation mucosal,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
108,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
108,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
108,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
108,5,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
109,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
110,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
110,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
110,3,Hepatorenal failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
110,4,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
110,5,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
110,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
110,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
110,8,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
110,9,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
110,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
110,11,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
110,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
111,2,Pharyngeal ulceration,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
111,3,Scrotal ulcer,Scrotal disorders NEC,Penile and scrotal disorders (excl infections and inflammations),Repro,N
112,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
112,2,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
112,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
112,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
113,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
114,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
114,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
114,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
115,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
116,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
116,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
117,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
118,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
118,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
119,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
119,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
119,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
119,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
120,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
120,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
120,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
121,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
122,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
123,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
124,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
125,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
126,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
127,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
127,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
127,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
127,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
128,2,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
129,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
129,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
129,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
130,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
131,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
132,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
132,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
133,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
133,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
133,3,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
134,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
135,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
136,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
137,1,Disseminated cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,Y
137,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
138,1,Idiopathic intracranial hypertension,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
139,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
140,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
140,2,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
141,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
142,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
143,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
143,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
144,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
144,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
145,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
146,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
146,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
147,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
148,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
148,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
148,3,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
149,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
149,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
149,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
150,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
151,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
151,2,Hepatitis cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
151,3,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
151,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
152,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
153,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
154,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
155,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
155,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
156,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
156,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
157,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
158,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
158,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
159,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
160,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
160,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
160,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
160,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
161,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
162,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
163,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
163,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
163,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
164,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
165,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
166,1,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
167,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
167,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
167,3,Peripheral circulatory failure,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
168,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
169,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
170,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
170,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
170,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
170,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
171,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
171,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
171,3,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
172,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
173,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
173,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
174,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
174,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
174,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
175,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
176,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
177,1,Deafness,Hearing losses,Hearing disorders,Ear,N
177,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
178,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
179,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
179,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
179,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
180,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
181,1,Ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
181,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
182,1,Deafness,Hearing losses,Hearing disorders,Ear,N
183,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
183,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
184,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
185,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
186,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
187,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
187,2,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
187,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
187,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
187,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
188,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
188,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
188,3,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
189,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
189,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
189,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
189,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
189,5,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
190,1,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
191,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
192,1,Enamel anomaly,Dental surface disorders,Dental and gingival conditions,Gastr,N
192,2,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
193,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
194,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
195,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
196,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
197,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
197,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
197,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
198,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
199,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
200,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
200,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
201,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
201,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
202,1,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
202,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
202,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
203,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
203,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
203,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
203,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
203,5,Vascular pain,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
203,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
204,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
204,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
204,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
205,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
205,2,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
205,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
205,4,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
206,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
207,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
208,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
209,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
209,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
210,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
211,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
211,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
212,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
212,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
212,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
212,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
212,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
213,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
213,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
214,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
214,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
214,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
215,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
216,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
216,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
216,3,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
216,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
216,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
217,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
217,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
217,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
217,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
217,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
218,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
218,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
218,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
218,4,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
218,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
218,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
219,1,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
220,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
220,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
220,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
220,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
220,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
221,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
221,2,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
221,3,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
222,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
222,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
223,1,Deafness,Hearing losses,Hearing disorders,Ear,N
224,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
225,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
226,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
226,2,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
227,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
228,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
228,2,Deafness bilateral,Hearing losses,Hearing disorders,Ear,N
228,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
229,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
229,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
229,3,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
230,1,Deafness,Hearing losses,Hearing disorders,Ear,N
230,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
231,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
232,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
233,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
233,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
233,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
234,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
235,1,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
235,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
235,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
236,1,Erythema nodosum,Panniculitides,Skin and subcutaneous tissue disorders NEC,Skin,N
237,1,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
238,1,VIth nerve paralysis,Eye movement disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
239,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
240,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
240,2,Cheyne-Stokes respiration,Breathing abnormalities,Respiratory disorders NEC,Resp,N
241,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
242,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
243,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
243,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
243,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
244,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
245,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
245,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
246,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
247,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
247,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
247,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
247,4,Headache,Headaches NEC,Headaches,Nerv,N
248,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
248,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
248,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
248,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
249,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
249,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
249,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
250,1,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
250,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
251,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
252,1,Neuritis,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
252,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
253,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
254,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
254,2,Sinus bradycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
254,3,Ventricular extrasystoles,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
255,1,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
256,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
256,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
257,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
257,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
257,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
258,1,Soft tissue inflammation,Inflammations,General system disorders NEC,Genrl,N
259,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
260,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
261,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
262,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
262,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
263,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
263,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
263,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
263,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
263,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
264,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
264,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
265,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
265,2,Anembryonic gestation,Abortion related conditions and complications,Abortions and stillbirth,Preg,N
266,1,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
267,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
268,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
268,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
268,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
268,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
268,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
268,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
269,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
269,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
270,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
271,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
271,2,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
271,3,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
271,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
272,1,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
272,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
273,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
274,1,Deafness,Hearing losses,Hearing disorders,Ear,N
274,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
275,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
275,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
276,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
277,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
278,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
279,1,Cyanosis central,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
279,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
279,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
280,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
281,1,Deafness,Hearing losses,Hearing disorders,Ear,N
282,1,Dermatitis exfoliative,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
282,2,Infusion site inflammation,Infusion site reactions,Administration site reactions,Genrl,N
282,3,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
282,4,Injection site extravasation,Injection site reactions,Administration site reactions,Genrl,N
282,5,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
283,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
283,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
283,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
284,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
284,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
284,3,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
284,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
285,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
285,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
286,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
286,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
286,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
287,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
287,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
287,3,Hepatosplenomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
287,4,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
287,5,Serum ferritin abnormal,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
288,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
289,1,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
290,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
291,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
291,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
291,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
292,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
293,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
293,2,Granuloma,Inflammations,General system disorders NEC,Genrl,N
294,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
294,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
295,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
296,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
297,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
297,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
298,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
299,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
300,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
301,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
302,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
302,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
303,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
304,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
305,1,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
305,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
305,3,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
306,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
307,1,Diabetes insipidus,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
308,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
308,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
308,3,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
309,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
309,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
309,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
310,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
311,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
312,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
313,1,Normochromic normocytic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
314,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
314,2,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
314,3,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
315,1,Anaphylactoid reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
316,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
316,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
317,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
318,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
318,2,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
318,3,Central venous pressure increased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
318,4,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
318,5,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
318,6,Muscle rigidity,Muscle tone abnormalities,Muscle disorders,Musc,N
318,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
318,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
319,1,Angiodysplasia,Vascular malformations and acquired anomalies,Vascular disorders NEC,Vasc,N
319,2,Gastrointestinal ulcer,"Gastrointestinal ulcers and perforation, site unspecified",Gastrointestinal ulceration and perforation,Gastr,N
319,3,Large intestinal ulcer,Intestinal ulcers and perforation NEC,Gastrointestinal ulceration and perforation,Gastr,N
319,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
320,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
320,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
320,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
320,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
320,5,Vulvovaginitis,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
321,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
321,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
321,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
321,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
321,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
321,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
321,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
321,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
321,9,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
321,10,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
321,11,Tongue oedema,Tongue signs and symptoms,Tongue conditions,Gastr,N
322,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
323,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
324,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
324,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
324,3,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
324,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
325,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
325,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
326,1,Nephrogenic diabetes insipidus,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
327,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
327,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
327,3,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,Y
328,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
328,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
329,1,Haemoglobinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
329,2,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
329,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
330,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
330,2,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
330,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
330,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
330,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
331,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
331,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
331,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
331,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
332,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
332,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
332,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
332,4,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
333,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
333,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
333,3,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
334,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
334,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
335,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
335,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
335,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
335,4,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
335,5,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
335,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
336,1,Arrhythmia supraventricular,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
336,2,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
336,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
336,4,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
336,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
337,1,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
338,1,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
339,1,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
340,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
341,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
342,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
343,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
344,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
345,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
346,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
346,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
346,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
347,1,Hyperphosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
347,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
348,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
348,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
348,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
348,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
348,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
349,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
349,2,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
349,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
349,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
350,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
350,2,Immobile,Disability issues,Lifestyle issues,SocCi,N
351,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
351,2,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
351,3,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
351,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
351,5,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
351,6,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
352,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
352,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
352,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
352,4,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
353,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
353,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
353,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
353,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
353,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
353,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
353,7,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
353,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
354,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
354,2,Tooth erosion,Dental disorders NEC,Dental and gingival conditions,Gastr,N
355,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
356,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
356,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
357,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
357,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
358,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
359,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
360,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
360,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
361,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
361,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
361,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
361,4,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
361,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
362,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
363,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
364,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
364,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
365,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
365,2,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
365,3,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
365,4,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
365,5,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
365,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
366,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
367,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
368,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
368,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
368,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
368,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
368,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
369,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
370,1,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
370,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
370,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
371,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
371,2,Bradyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
371,3,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
371,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
371,5,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
371,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
371,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
371,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
371,9,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
371,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
372,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
373,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
374,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
374,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
374,3,Myocarditis,Noninfectious myocarditis,Myocardial disorders,Card,N
375,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
375,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
376,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
377,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
378,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
379,1,Blood creatine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
379,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
379,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
380,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
380,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
380,3,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
381,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
381,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
381,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
381,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
382,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
382,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
382,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
382,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
382,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
383,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
384,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
385,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
386,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
387,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
387,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
388,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
389,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
389,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
390,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
390,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
390,3,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
390,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
391,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
391,2,Infusion related reaction,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
392,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
393,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
394,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
394,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
395,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
395,2,Multiple-drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
396,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
397,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
397,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
397,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
397,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
397,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
397,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
397,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
397,8,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
397,9,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
398,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
399,1,Deafness,Hearing losses,Hearing disorders,Ear,N
400,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
401,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,2,Systemic inflammatory response syndrome,Inflammations,General system disorders NEC,Genrl,N
402,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
402,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
402,3,Gamma-glutamyltransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
402,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
403,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
403,2,Deafness neurosensory,Hearing losses,Hearing disorders,Ear,N
404,1,Enterococcus test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
404,2,Haematological malignancy,Haematologic neoplasms NEC,Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,Y
404,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
404,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
405,1,Dacryocanaliculitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
405,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
405,3,Eye abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
405,4,Keratitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
405,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
406,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
406,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
406,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
407,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
408,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
409,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
410,1,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
411,1,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
411,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
412,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
412,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
412,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
413,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
413,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
414,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
414,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
414,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
415,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
416,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
417,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
418,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
419,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
420,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
420,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
420,3,Cardio-respiratory arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
420,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
420,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
420,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
420,7,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
420,8,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
420,9,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
420,10,Mycobacterium fortuitum infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
420,11,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
420,12,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
420,13,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
420,14,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
420,15,Sepsis syndrome,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
420,16,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
421,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
422,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
422,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
422,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
422,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
423,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
423,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
424,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
424,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
424,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
425,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
425,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
425,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
426,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
426,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
426,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
426,4,Eye irritation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
426,5,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
426,6,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
426,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
426,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
426,9,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
426,10,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
427,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
428,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
428,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,Y
429,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
429,2,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
430,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
431,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
432,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
433,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
434,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
435,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
436,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
437,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
438,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
438,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
439,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
439,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
439,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
440,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
441,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
441,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
441,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
442,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
442,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
442,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
443,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
444,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
444,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
445,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
446,1,Clostridium difficile infection,Clostridia infections,Bacterial infectious disorders,Infec,N
447,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
447,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
447,3,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
447,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
447,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
448,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
449,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
450,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
451,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
452,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
453,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
454,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
455,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
456,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
457,1,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
457,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
457,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
458,1,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
458,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
459,1,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
459,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
460,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
460,2,Respiratory tract infection fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
461,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
461,2,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
461,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
461,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
461,5,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
461,6,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
462,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
462,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
462,3,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
462,4,Cervix enlargement,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
462,5,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
462,6,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
462,7,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
462,8,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
462,9,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
462,10,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
462,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
462,12,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
462,13,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
462,14,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
462,15,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
462,16,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
462,17,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
462,18,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
462,19,Splenomegaly,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
462,20,Streptococcal infection,Streptococcal infections,Bacterial infectious disorders,Infec,N
462,21,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
462,22,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
463,1,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
464,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
465,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
466,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
467,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
468,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
469,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
470,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
471,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
472,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
473,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
474,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
475,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
476,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
477,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
478,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
479,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
479,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
480,1,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
481,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
481,2,Oral mucosal exfoliation,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
481,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
482,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
482,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
482,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
483,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
484,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
484,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
484,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
485,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
486,1,Tachyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
487,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
488,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
488,2,Hepatic lesion,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
488,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
488,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
488,5,Systemic mycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
489,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
490,1,Headache,Headaches NEC,Headaches,Nerv,N
490,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
490,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
491,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
492,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
493,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
493,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
493,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
494,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
494,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
494,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
494,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
494,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
494,6,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
494,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
494,8,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
494,9,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
495,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
496,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
497,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
497,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
498,1,Incorrect dosage administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
498,2,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
499,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
499,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
499,3,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
499,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
500,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
501,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
502,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
503,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
503,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
503,3,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
503,4,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,Y
504,1,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
504,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
504,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
504,4,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
504,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
504,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
505,1,Ebola disease,Filovirus viral infections,Viral infectious disorders,Infec,N
506,1,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
506,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
507,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
508,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
509,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
510,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
511,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
512,1,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
513,1,Pancreatitis necrotising,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
514,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
514,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
514,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
514,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
514,5,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
514,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
515,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
515,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
515,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
515,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
516,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
517,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
517,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
518,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
519,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
520,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
521,1,Infection in an immunocompromised host,Infections NEC,Infections - pathogen unspecified,Infec,N
521,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
522,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
522,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
522,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
522,4,Corynebacterium infection,Corynebacteria infections,Bacterial infectious disorders,Infec,N
522,5,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
522,6,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
522,7,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
522,8,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
522,9,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
522,10,Mechanical ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
522,11,Pseudomonas infection,Pseudomonal infections,Bacterial infectious disorders,Infec,N
522,12,Renal transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
522,13,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
522,14,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
522,15,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
523,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
524,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
524,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
524,3,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
524,4,Headache,Headaches NEC,Headaches,Nerv,N
524,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
525,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
526,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
527,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
528,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
529,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
529,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
530,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
530,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
531,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
531,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
531,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
532,1,Deafness,Hearing losses,Hearing disorders,Ear,N
532,2,Ototoxicity,Ear disorders NEC,Aural disorders NEC,Ear,N
533,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
533,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
533,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
533,4,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
533,5,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
533,6,Wrong product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
534,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
535,1,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
536,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
536,2,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
536,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
537,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
537,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
538,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
539,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
539,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
540,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
540,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
540,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
541,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
541,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
541,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
542,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
543,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
543,2,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
544,1,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
544,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
544,3,Pneumonia moraxella,Moraxella infections,Bacterial infectious disorders,Infec,N
544,4,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
545,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
545,2,Cryptococcosis,Cryptococcal infections,Fungal infectious disorders,Infec,N
545,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
545,4,Delayed graft function,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
545,5,Diabetic retinopathy,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
545,6,Escherichia urinary tract infection,Escherichia infections,Bacterial infectious disorders,Infec,N
545,7,Headache,Headaches NEC,Headaches,Nerv,N
545,8,Optic discs blurred,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
545,9,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
545,10,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
545,11,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
546,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
547,1,Cardiotoxicity,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
548,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
549,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
550,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
550,2,Periorbital cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
550,3,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,Y
551,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
551,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
551,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
551,4,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
551,5,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
551,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
551,7,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
551,8,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
552,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
552,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
552,3,Enterococcus test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
552,4,Haemorrhagic disorder,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
552,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
552,6,Mediastinal shift,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
552,7,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
553,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
553,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
553,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
554,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
555,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
556,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
556,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
556,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
556,4,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
557,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
557,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
558,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
559,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
559,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
560,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
560,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
560,3,Infusion site rash,Infusion site reactions,Administration site reactions,Genrl,N
560,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
561,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
561,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
561,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
562,1,Bronchospasm,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
562,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
562,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
562,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
563,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
564,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
565,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
565,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
566,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
567,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
568,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
568,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
568,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
568,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
568,5,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
568,6,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
568,7,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
568,8,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
568,9,Hepatic infarction,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
568,10,Intestinal infarction,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
568,11,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
568,12,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
568,13,Renal infarct,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
568,14,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
569,1,Lactic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
569,2,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
570,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
571,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
572,1,Histoplasmosis,Histoplasma infections,Fungal infectious disorders,Infec,N
573,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
574,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
574,2,Lung lobectomy,Bronchial and pulmonary therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
575,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
575,2,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,Y
575,3,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
575,4,Pseudomonal sepsis,Pseudomonal infections,Bacterial infectious disorders,Infec,N
575,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
576,1,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
576,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
576,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
577,1,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
577,2,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
577,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
578,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
579,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
579,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
579,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
580,1,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
580,2,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
581,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
582,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
583,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
584,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
584,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
585,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
585,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
586,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
586,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
587,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
587,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
588,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
588,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
589,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
589,2,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
590,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
591,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
591,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
592,1,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
593,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
593,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
594,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
594,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
594,3,Visceral leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
595,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
595,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
596,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
596,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
596,3,Cardiac valve vegetation,Cardiac infections,Infections - pathogen unspecified,Infec,N
596,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
596,5,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,Y
596,6,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
596,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
596,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
596,9,Right atrial hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
596,10,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
596,11,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
597,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
597,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
597,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
597,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
598,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
598,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
598,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
599,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
600,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
600,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
601,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
602,1,Leishmaniasis,Leishmania infections,Protozoal infectious disorders,Infec,N
602,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
603,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
604,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
605,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
606,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
607,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
607,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
607,3,Potassium wasting nephropathy,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
607,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
608,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
609,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
610,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
611,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
612,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
613,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
613,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
613,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
614,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
615,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
615,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
616,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
617,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
618,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
618,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
619,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
620,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
620,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
621,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
621,2,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
621,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
622,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
623,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
623,2,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
623,3,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
623,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
623,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
624,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
624,2,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
624,3,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
624,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
624,5,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
625,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
626,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
626,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
627,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
628,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
629,1,Blood copper increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
629,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
630,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
631,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
632,1,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
633,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
633,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
633,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
634,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
634,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
635,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
635,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
635,3,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
635,4,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
635,5,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
636,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
637,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
637,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
637,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
637,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
637,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
637,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
637,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
637,8,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
637,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
637,10,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
638,1,CNS ventriculitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,Y
638,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
638,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
639,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
640,1,Choking sensation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
640,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
640,3,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
640,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
640,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
641,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
642,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
643,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
643,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
643,3,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
643,4,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
643,5,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
643,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
643,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
644,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
645,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
645,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
645,3,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,Y
645,4,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
645,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
646,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
646,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
646,3,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
646,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
647,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
647,2,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
647,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
648,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
648,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
649,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
650,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
651,1,Liver disorder,Hepatic and hepatobiliary disorders NEC,Hepatic and hepatobiliary disorders,Hepat,N
651,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
651,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
652,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
653,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
653,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
654,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
655,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
656,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
657,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
658,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
659,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
660,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
660,2,Drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
661,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
661,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
662,1,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
663,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
664,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
664,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
664,3,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
665,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
666,1,Cytokine release syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
666,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
666,3,Immune effector cell-associated neurotoxicity syndrome,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
666,4,Neurotoxicity,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
667,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
667,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
667,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
668,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
668,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
668,3,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
668,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
668,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
668,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
668,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
668,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
668,9,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
669,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
669,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
669,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
670,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
670,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
670,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
671,1,Corneal oedema,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
671,2,Dacryocanaliculitis,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
671,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
671,4,Eye abscess,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
671,5,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
671,6,Keratitis,"Corneal infections, oedemas and inflammations","Ocular infections, irritations and inflammations",Eye,N
671,7,Keratitis fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
671,8,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
672,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
673,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
673,2,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
674,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
674,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
674,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
674,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
674,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
675,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
676,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
677,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
678,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
679,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
680,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,Y
681,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
682,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
683,1,Disseminated aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
683,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
683,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
684,1,Disseminated aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
684,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
684,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
685,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
686,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
687,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
688,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
689,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
690,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
691,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
692,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
693,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
693,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
694,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
694,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
695,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
695,2,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
695,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
695,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
696,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
696,2,Pneumothorax spontaneous,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
696,3,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
697,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
697,2,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
697,3,Flavobacterium infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
697,4,Fusarium infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
697,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
697,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
697,7,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
697,8,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
697,9,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
698,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
698,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
699,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
700,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
700,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
701,1,Aspergillus test positive,Fungus identification and serology,Microbiology and serology investigations,Inv,N
701,2,Blood creatinine abnormal,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
701,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
701,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
701,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
701,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
701,7,Procalcitonin increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
701,8,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
702,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
702,2,Lung disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
703,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
704,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
704,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
704,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
704,4,Headache,Headaches NEC,Headaches,Nerv,N
704,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
704,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
704,7,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
704,8,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
704,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
704,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
704,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
705,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
706,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
707,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
707,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
707,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
707,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
707,5,Headache,Headaches NEC,Headaches,Nerv,N
707,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
707,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
707,8,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
707,9,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
707,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
707,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
707,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
708,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
709,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
710,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
710,2,Brain abscess,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
710,3,Cerebral microhaemorrhage,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
710,4,Granuloma,Inflammations,General system disorders NEC,Genrl,N
710,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
711,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
711,2,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
711,3,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
712,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
712,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
712,3,Fungal endocarditis,Fungal infections NEC,Fungal infectious disorders,Infec,N
713,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
713,2,Meningitis cryptococcal,Cryptococcal infections,Fungal infectious disorders,Infec,Y
713,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
713,4,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
714,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
715,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
716,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
716,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
717,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
717,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
718,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
719,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
719,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
720,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
721,1,Aspergillus infection,Aspergillus infections,Fungal infectious disorders,Infec,N
721,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
721,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
722,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
722,2,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
723,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
724,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
724,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
724,3,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
724,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
724,5,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
724,6,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
724,7,Pulmonary necrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
724,8,Steroid diabetes,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
724,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
725,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
726,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
726,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
726,3,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
726,4,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
726,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
726,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
727,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
728,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
728,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
729,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
730,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,Y
730,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
730,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
730,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
730,5,Exophthalmos,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
730,6,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
730,7,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
730,8,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
730,9,Ophthalmoplegia,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
730,10,Palate injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
731,1,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
731,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
732,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
732,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
732,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
733,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
734,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
734,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
735,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
735,2,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
736,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
737,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
737,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
738,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
739,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
739,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
739,3,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
739,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
740,1,Disseminated mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
740,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
740,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
740,4,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
740,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
740,6,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
740,7,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
741,1,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
742,1,Lactobacillus infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
742,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
742,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
743,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
743,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
744,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
745,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
745,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
745,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
745,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
746,1,Chest tube insertion,Chest wall and mediastinal therapeutic procedures,Respiratory tract therapeutic procedures,Surg,N
746,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
746,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
746,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
746,5,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
746,6,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
746,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
747,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
748,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
749,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
750,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
751,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
752,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
752,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
753,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
753,2,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
753,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
754,1,Disseminated mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,N
754,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
755,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
755,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
755,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
756,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
756,2,Nephropathy toxic,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
757,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
757,2,Bradyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
757,3,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
757,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
757,5,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
757,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
757,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
757,8,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
757,9,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
757,10,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
758,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
758,2,Bradyarrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
758,3,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
758,4,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
758,5,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
758,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
758,7,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
758,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
759,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
760,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
760,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
761,1,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
762,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
763,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
764,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
765,1,Mucormycosis,Fungal infections NEC,Fungal infectious disorders,Infec,Y
765,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
766,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
766,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
767,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
767,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
767,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
768,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
